Detalles de la búsqueda
1.
Impact of hospitalisation on health-related quality of life in patients with chronic heart failure.
Health Qual Life Outcomes
; 18(1): 262, 2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32746842
2.
Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis.
Value Health
; 21(2): 193-202, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29477401
3.
The increasing importance of a continence nurse specialist to improve outcomes and save costs of urinary incontinence care: an analysis of future policy scenarios.
BMC Fam Pract
; 19(1): 31, 2018 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454331
4.
A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data.
Value Health
; 20(8): 1041-1047, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28964435
5.
Determining the impact of modeling additional sources of uncertainty in value-of-information analysis.
Value Health
; 18(1): 100-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25595240
6.
Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
J Allergy Clin Immunol
; 132(2): 353-60.e2, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23651609
7.
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial.
Eur Respir J
; 41(3): 556-64, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22700844
8.
Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients.
PLoS One
; 17(1): e0261940, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35089941
9.
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
Drugs Real World Outcomes
; 9(2): 275-285, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314962
10.
Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.
Value Health
; 14(8): 1039-47, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22152172
11.
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands.
Crit Care
; 14(6): R195, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21040558
12.
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations.
Eur J Health Econ
; 21(1): 153-164, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31541309
13.
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.
Appl Health Econ Health Policy
; 17(6): 883-893, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31317510
14.
First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis.
Onco Targets Ther
; 12: 1413-1421, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30863108
15.
Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 37(2): 141-153, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194622
16.
Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands.
Value Health
; 11(4): 589-99, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18194404
17.
Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research.
Value Health
; 11(7): 1070-80, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19602213
18.
Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force.
Value Health
; 16(6): 1106-7, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041364
19.
Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis.
PLoS One
; 13(10): e0205013, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30289926
20.
Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
Pharmacoeconomics
; 36(2): 145-159, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29086363